Axcella Therapeutics

Closed

Cambridge, United States · Founded 2009

Founded
2009
Business Model
B2B

About

Axcella Health (formerly Axcella Therapeutics, formerly Pronutria Biosciences) was a clinical-stage biotechnology company based in Cambridge, Massachusetts, pioneering the use of endogenous metabolic modulators (EMMs) to treat complex metabolic, muscle, and neurological diseases. Founded in 2009 as a Flagship Pioneering company and listed on Nasdaq (AXLA), it developed multi-targeted EMM compositions informed by systems biology and machine learning. The company shut down in December 2023 following an SEC filing disclosing closure.

Summary

Axcella Therapeutics is a Biotech company based in Cambridge, United States, founded in 2009.

Similar Companies